PPARG and colitis: Pioglitazone ameliorates DSS‐induced colitis and attenuates colitis‐associated mechanical hyperalgesia, with improving integrity of the intestinal mucosal barrier by directly upregulating tight junction protein ZO‐1 through the PPARγ‐tight junction protein signaling.22